BrainScope Company, Inc.
12
0
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.3%
1 terminated/withdrawn out of 12 trials
90.9%
+4.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Do EEG and Neurocognitive Assessments Correlate With COVID Brainfog Symptoms?
Role: collaborator
Follow-up of MTBI Patients Discharged from the ED Using Standard Clinical Triage Including BrainScope One
Role: lead
Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
Role: lead
Objective Brain Function Assessment of mTBI/Concussion
Role: lead
Objective Brain Function Assessment of mTBI/Concussion in High School Athletes
Role: lead
Validation of Brain Function Assessment Algorithm for mTBI/Concussion
Role: lead
Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes
Role: lead
Objective Brain Function Assessment of mTBI/Concussion in College Athletes
Role: lead
Validation Of TBI Detection System For Head Injured Patients
Role: lead
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Role: lead
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Role: lead
Observational Study of the BrainScope® Ahead™ M-100 in UK Emergency Department Patients With Head Injury
Role: lead
All 12 trials loaded